Progenics Pharmaceuticals

Pain drug morphine may accelerate cancer growth

CHICAGO (Reuters) - Evidence is mounting that morphine, commonly used to manage pain, may accelerate cancer growth, but a newly-approved drug that blocks its side effects could also keep tumors from spreading, U.S. researchers...

powered by

CORRECTING and REPLACING Progenics Announces Third Quarter 2009 Financial Results

In the October Highlights section, the third sentence in the second bullet should read xxx Significantly more patients on study drug experienced laxation within two and four hours compared to those on placebo (33% versus 0%, [p...

powered by

BioMed Realty Trust Extends Lease at Landmark With Progenics Pharmaceuticals

SAN DIEGO, Oct. 29 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. announced today that it has entered into a new ten-year lease with Progenics Pharmaceuticals, Inc. encompassing approximately 148,000 square feet at The...

powered by

BioMed Realty Trust Reports Third Quarter 2009 Operating and Financial Results

SAN DIEGO, Oct. 28 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. , a real estate investment trust focused on Providing Real Estate to the Life Science Industry®, today announced operating and financial results for the...

powered by

CKH, SGEN, CPX, SNWL, DLX, NTCT Expected To Be Higher After Earnings Releases on Thursday

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, October 22nd and determining how the stocks have performed after their last 12 quarterly, 6 quarterly and...

powered by

Progenics regains rights to Relistor from Wyeth

By Bill Berkrot NEW YORK, Oct 14 (Reuters) - Progenics Pharmaceuticals Inc said on Wednesday it reached a deal with Wyeth to regain worldwide rights to Relistor, a medicine used to treat constipation caused by opioid pain...

powered by

Cancer, Bowel Drugs on FDA Safety Scrutiny List

The agency also is reviewing gastrointestinal perforation reported with Relistor, a drug from Wyeth and Progenics Pharmaceuticals for treating opioid-induced constipation. (Wed Oct 07 14:03:57 2009 PDT)[$drug_related(100%),...

powered by

Cancer, bowel drugs on FDA safety scrutiny list

The agency also is reviewing gastrointestinal perforation reported with Relistor, a drug from Wyeth and Progenics Pharmaceuticals for treating opioid-induced constipation. ... (Wed Oct 07 14:03:57 2009 PDT)[$drug_related(100%),...

powered by

UPDATE 1-Cancer, bowel drugs on U.S. FDA safety scrutiny list

WASHINGTON, Oct 7 (Reuters) - More than a dozen drugs including a cancer therapy and a bowel medicine are under early scrutiny for potential side effects, U.S. regulators said in a quarterly list released on Thursday. The Food...

powered by

TER, CNO, FAF, SGEN, RT, KOF Expected To Be Lower Leading Up To Next Earnings Releases

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and...

powered by
1 2 3 4 next »